Abstract
To encapsulate a new copper coordination compound drug for triple-negative breast cancer treatment we have developed a new approach. The obtained liposomal suspension is stable up to 2 weeks; successful complex loading is confirmed spectrophotometrically and can be quantified by HPLC.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
